Mitral valve regurgitation: a plea for transcatheter mitral valve replacement
September 20, 2019 | 10.4244/EIJV15I7A103
Showing 1-10 of 10 articles
Interventions for valvular disease
Transcatheter Mitral Valve Replacement: Factors Associated with Screening Success and Failure. August 27, 2019 | 10.4244/EIJ-D-19-00444
PCR London Valves Innovators Day 2017. Where will valve intervention be in 2025?
November 20, 2017 | 10.4244/EIJV13I10A178
Transcatheter aortic valve implantation versus redo surgery for failing surgical aortic bioprostheses: a multicentre propensity score analysis
November 20, 2017 | 10.4244/EIJ-D-16-00303
Interventions for valvular disease
Repositionable percutaneous aortic valve implantation with the LOTUS valve: 30-day and 1-year outcomes in 250 high-risk surgical patients September 20, 2017 | 10.4244/EIJ-D-16-01024
Interventions for valvular disease
Insights into the need for permanent pacemaker following implantation of the repositionable LOTUS valve for transcatheter aortic valve replacement in 250 patients: results from the REPRISE II trial with extended cohort September 20, 2017 | 10.4244/EIJ-D-16-01025
Interventions for valvular disease
Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: systematic measurement methodology and inter-observer variability October 10, 2016 | 10.4244/EIJY15M11_09
Interventions for valvular disease
TAVI device selection: time for a patient-specific approach September 18, 2016 | 10.4244/EIJV12SYA9
Interventions for valvular disease
How should I treat a mitral prosthesis rupture after left ventricular assist device implantation? July 20, 2016 | 10.4244/EIJV12I4A89
Update on the need for a permanent pacemaker after transcatheter aortic valve implantation using the CoreValve® Accutrak™ system
September 28, 2012 | 10.4244/EIJV8I5A86
